VLA Comment: Amongst all this concern…have some fun…watch this video!

Two other states – Connecticut and Maine – have passed labeling laws, but both delayed implementation until neighboring states join them, a strategy designed to insulate them from being sued.  Read more…

VLA Comment:  The only impediment may be that the Federal Government will create a bill to stop labeling GMO products.  The government is very invested in “owning the world food supply” via multinational corporations like Monsanto, so we are likely to see a Federal bill.  On the inside, the divvying up of the future global currency pie will depend on “resources”.  The US will get a big piece of the pie as the controller of the world food supply.

According to reports, concerns first arose after several Fordham University students suddenly came down with flu-like symptoms in recent weeks, which later turned out to be adult mumps in every case. The infection numbers continued to swell, prompting an inquiry into the vaccination records of the affected students. But this inquiry revealed that not a single unvaccinated student had contracted the mumps — only those who had previously been vaccinated for mumps developed the disease. Read more…

Learn more: http://www.naturalnews.com/044087_vaccinated_students_mumps_outbreaks_fordham_university.html#ixzz2uYaQkNWL

Visit NBCNews.com for breaking news, world news, and news about the economy

“Under Observation” identifies patient as an “out patient”. 600,000 patents and more are being indentified as Under Observation instead of In-patient status.

The vaccine Pandemrix, (According to GSK, some 30 million doses of the vaccine were administered across Europe and 800 people, mostly children, developed narcolepsy) will be added to the national stockpile.The vaccine will not be available commercially; it will be placed in the U.S. government’s emergency stockpile, FDA said.

Letter of Acceptance from FDA

FDA site: GSK Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted with ASO3.

VLA comment: This newly approved “Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted is like Pandemrix, (Pandemrix, which has not been approved in the United States). It is also made by GSK and is almost identical in structure and has just been approved for our national stockpile. This vaccine contains the adjuvant ASO3 (contains Squalene) and (polysorbate 80) for use on the American people under Emergency Use Authorization*, so you won’t know what’s coming!  Generally unknown,  In June 23, 2011 the FDA approved Novartis FLUAD Influenza vaccine which contains a similiar adjuvant- MF596 (contains Squalene) and (polysorbate 80).

While GSK has acknowledged an association between the vaccine and the narcolepsy cases, it has said there is insufficient evidence to prove the adjuvant (ASO3) was to blame. Scientists believe AS03 may be the culprit in the narcolepsy cases though they have yet to decipher the precise nature of the association. Read article…

Read March 2013 Huffington Post…

GKS: The vaccine will be supplied in a kit consisting of one package containing 50 multidose vials of H5N1 antigen and two packages each containing 25 multidose vials of AS03 adjuvant. Since, as stated in your November 11, 2013, submission, you do not intend to market this product for commercial distribution. (Stockpiling for emergency authorization use). “Supporting the U.S. Government’s capability to help protect Americans against pandemics ranks among GSK’s most important U.S. public-health responsibilities,” said Bruce Innis, Vice President of Vaccines Development for GSK. “H5N1-related illness has thus far been rare, but life-threatening when it has occurred”.

GSK will make this vaccine available in the U.S. only if directed to by the Biomedical Advanced Development and Research Authority (BARDA) in the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response. The GSK H5N1 pandemic influenza vaccine programme has been supported by a development contract (HHSO100200700029C) from BARDA. GSK’s Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, has also received marketing authorisation in Europe and Canada under the brand names, Pumarix™ and Arepanrix™ H5N1, respectively. Read more…

Pumarix: Glaxo’s super-charged product is the first to show it can confer protection in the event of a pandemic. European regulators have approved it under the brand name Pumarix  (contains Squalene) and (polysorbate 80)

Read more…

Some ingredients of the FDA approved vaccine (Nov. 22, 2013): ASO3, (contains Squalene) (polysorbate 80) & Thimerosal (mercury),

Division of Chemical, Biological, Radiological and Nuclear Medical Countermeasures (CBRN MCM)

Stockpiling Lifesaving MCMs
The Division of CBRN MCMs is responsible for developing and establishing stockpiles of lifesaving vaccines, drugs, and diagnostics against CBRN threats. The Project BioShield Act of 2004 established the Special Reserve Fund (SRF), a one-time appropriation of $5.6 billion (2004 – 2013) to accelerate the research, development and acquisition of MCMs against CBRN threat agents. Eight Project BioShield programs have led to the acquisition of MCMs for the Strategic National Stockpile (SNS). These include an anthrax vaccine for post-exposure prophylaxis, anthrax therapeutics, a novel smallpox vaccine, a smallpox antiviral drug, a botulinum antitoxin, and radiation countermeasures. Read more…

MUST READ…Bioshield Annual Report (2012) 

All Annual Bioshield Reports

*Emergency Use Authorization for Medical Counter-measures– Section 4 of the Act allows the HHSSecretary to issue an Emergency Use Authorization (EUA) after an emergency has been declared by the Secretary as described in the “Statutory Authority”section found on page 7. The EUA declaration justifies the use of a FDA-approved, licensed, or cleared product for an unapproved indication or an unapproved product for an indication over a specified period of time during the emergency.

Dr. Paul G. King’s Guide to the No – Thimerosal Influenza Vaccine Choices in the USA for the 2013 – 2014 Flu Season Read Pdf…

Vaccine exemption forms

Vaccine Exemption form Australia

Dr. Paul G. King, vaccine consultant for the National Coalition of Organized Women outlines herein why all vaccines, accordingly, should be re-classified as adulterated until the safety requirements are met.

Under 21 U.S.C. § 351(a)(2)(B)
Any failure to meet any safety requirement deems a drug to be adulterated. Rational: Therefore, according to Dr. Paul G. King’s paper  one could argue that all of today’s FDA-approved vaccines are adulterated drugs, which are currently illegal and have been, heretofore, illegally placed in commerce. Further rational: Adulterated drugs (vaccines) cannot legally be listed on the National Vaccine Injury Compensation table. Therefore, it can be argued that the vaccine injured are not compelled to apply to the NVIC for compensation and are free to litigate in US Courts without first making application to the NVIC program.  Read argument…